Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 408421000001110 | Xylometazoline + Ipratropium | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 408441000001117 | Xylometazoline + Ipratropium (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xylometazoline + Ipratropium | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Xylometazoline + Ipratropium | Is a | Product containing xylometazoline | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xylometazoline 70micrograms/dose / Ipratropium bromide 84micrograms/dose nasal spray | Is a | True | Xylometazoline + Ipratropium | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR